Biotts, the biopharmaceutical company developing the unique and patented MTC-Y transdermal drug delivery technology, has been granted another patent in the US. The patent covers the MTC-A4 formulation, which has anaesthetic properties and is effective within minutes of application (compared to around 30 minutes for competing products). Expanding the patent cloud is extremely important from […]
Read the full article